One patient is currently undergoing treatment at Bharati Hospital, while the other, who was admitted to Deenanath Mangeshkar ...

Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside chat at TD Cowen’s 46th Annual Healthcare Conference, with President and ...

Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that the Food and Drug Administration (FDA) ...

If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, March 4, 2026 /PRNewswire/ -- Hansa Biopharma ...

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Barré Syndrome led to her being declared dead. After a medical error caused heart attacks, her husband's unwavering ...